Asensus Surgical, Inc. (NYSEAMERICAN:ASXC – Get Rating) was the recipient of some unusual options trading on Tuesday. Traders bought 7,652 call options on the company. This represents an increase of 2,368% compared to the typical daily volume of 310 call options.

Asensus Surgical Stock Performance

Shares of ASXC opened at $0.68 on Wednesday. The firm has a market cap of $162.30 million, a price-to-earnings ratio of -2.12 and a beta of 1.78. The company has a fifty day moving average of $0.55. Asensus Surgical has a fifty-two week low of $0.28 and a fifty-two week high of $1.18.

Asensus Surgical (NYSEAMERICAN:ASXC – Get Rating) last posted its earnings results on Thursday, March 2nd. The company reported ($0.07) earnings per share for the quarter, meeting the consensus estimate of ($0.07). The business had revenue of $2.46 million for the quarter, compared to analyst estimates of $2.50 million. Asensus Surgical had a negative net margin of 1,066.19% and a negative return on equity of 54.59%. Equities research analysts anticipate that Asensus Surgical will post -0.26 EPS for the current year.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright decreased their target price on shares of Asensus Surgical from $3.00 to $2.00 and set a "buy" rating for the company in a research note on Monday, March 6th.

Insider Activity

In related news, Director Andrea Biffi acquired 293,077 shares of the business's stock in a transaction dated Friday, March 3rd. The shares were acquired at an average price of $0.71 per share, with a total value of $208,084.67. Following the completion of the transaction, the director now owns 492,815 shares of the company's stock, valued at $349,898.65. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 1.50% of the company's stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the business. Ergoteles LLC acquired a new position in Asensus Surgical during the 1st quarter valued at about $36,000. Virtu Financial LLC bought a new stake in shares of Asensus Surgical in the 2nd quarter worth approximately $30,000. Renaissance Technologies LLC raised its holdings in shares of Asensus Surgical by 58.5% in the 4th quarter. Renaissance Technologies LLC now owns 152,473 shares of the company's stock worth $53,000 after purchasing an additional 56,300 shares in the last quarter. Goldman Sachs Group Inc. raised its holdings in shares of Asensus Surgical by 68.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 210,737 shares of the company's stock worth $133,000 after purchasing an additional 85,487 shares in the last quarter. Finally, AQR Capital Management LLC bought a new stake in shares of Asensus Surgical in the 2nd quarter worth approximately $106,000. 11.96% of the stock is owned by institutional investors and hedge funds.

About Asensus Surgical

(Get Rating)

Asensus Surgical, Inc is a medical device company, which digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities like augmented intelligence, connectivity and robotics in laparoscopy, and addresses the current clinical, cognitive, and economic shortcomings in surgery.

Featured Articles

• Get a free copy of the StockNews.com research report on Asensus Surgical (ASXC)
• Weight Watchers Reshapes Itself with a Game-Changer Acquisition
• Two Tiny Mining Stocks Worth Considering for the Next Gold Rush
• Nano Dimension Prints Growth: Enters Hypergrowth Phase
• CF Is Set To Harvest The Bull Run In Agricultural Stocks
• Oracle Dips But The Trend Is Strong

Receive News & Ratings for Asensus Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Asensus Surgical and related companies with MarketBeat.com's FREE daily email newsletter.